Loading...

Solventum Corporation

SOLVNYSE
HealthcareMedical - Care Facilities
$74.84
$-0.53(-0.70%)

Solventum Corporation SOLV Peers

See (SOLV) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Care Facilities Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
SOLV$74.84-0.70%12.9B34.49$2.17N/A
HCA$384.13+0.69%92.4B17.06$22.52+0.71%
FMS$28.51-0.49%16.7B23.76$1.20+2.40%
THC$171.38-0.27%15.9B10.99$15.60N/A
EHC$121.61+0.26%12.3B25.07$4.85+0.54%
UHS$189.36+0.14%12.2B10.61$17.85+0.42%
DVA$137.88+0.10%10.4B13.68$10.08N/A
OSH$39.00+0.08%9.5B-17.65-$2.21N/A
ENSG$152.38+0.45%8.8B28.75$5.30+0.16%
CHE$561.94+0.21%8.2B27.71$20.28+0.36%
Showing 1 to 10 of 81 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

SOLV vs HCA Comparison

SOLV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SOLV stands at 12.9B. In comparison, HCA has a market cap of 92.4B. Regarding current trading prices, SOLV is priced at $74.84, while HCA trades at $384.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SOLV currently has a P/E ratio of 34.49, whereas HCA's P/E ratio is 17.06. In terms of profitability, SOLV's ROE is +0.12%, compared to HCA's ROE of -2.36%. Regarding short-term risk, SOLV is more volatile compared to HCA. This indicates potentially higher risk in terms of short-term price fluctuations for SOLV.

Stock Price Comparison

Loading...

Frequently Asked Questions